Position in LLY
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$10,431,443
+$2,584,886 QoQ
Shares Held
8,697
+1.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.63%
of 13F equity value
Holder Rank
#1,240
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Capital Investment Advisory Services, LLC holds $45,032,363 across 13 Drug Manufacturers - General names. LLY ranks #1 (23.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
8,697 | $10,431,443 | |
| 2 | JNJ |
Johnson & Johnson
|
35,778 | $9,086,538 | |
| 3 | ABBV |
AbbVie Inc.
|
35,075 | $8,826,273 | |
| 4 | PFE |
Pfizer Inc
|
200,077 | $4,817,854 | |
| 5 | MRK |
Merck & Co., Inc.
|
29,988 | $3,853,458 | |
| 6 | AMGN |
Amgen Inc
|
8,846 | $3,203,313 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
32,911 | $1,896,331 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
6,218 | $785,582 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,431,443 | 8,697 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $7,846,557 | 8,531 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $9,343,268 | 8,694 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $6,710,585 | 8,795 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $6,824,785 | 8,755 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $6,676,656 | 8,084 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $5,949,804 | 7,707 | Shares | Sole | 2025-01-23 | |
| 2024-09-30 | $6,939,568 | 7,833 | Shares | Sole | 2024-10-30 | |
| 2024-06-30 | $4,751,434 | 5,248 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $3,754,434 | 4,826 | Shares | Sole | 2024-04-25 | |
| 2023-12-31 | $2,708,829 | 4,647 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $2,531,493 | 4,713 | Shares | Sole | 2023-11-02 | |
| 2023-06-30 | $2,005,827 | 4,277 | Shares | Sole | 2023-07-28 | |
| 2023-03-31 | $2,191,706 | 6,382 | Shares | Sole | 2023-04-21 | |
| 2022-12-31 | $2,754,409 | 7,529 | Shares | Sole | 2023-02-03 | |
| 2022-09-30 | $2,327,149 | 7,197 | Shares | Sole | 2022-10-26 | |
| 2022-06-30 | $2,423,943 | 7,476 | Shares | Sole | 2022-07-22 | |
| 2022-03-31 | $2,287,809 | 7,989 | Shares | Sole | 2022-05-03 | |
| 2021-12-31 | $1,919,729 | 6,950 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $1,349,563 | 5,841 | Shares | Sole | 2021-10-28 | |
| 2021-06-30 | $1,163,666 | 5,070 | Shares | Sole | 2021-07-27 | |
| 2021-03-31 | $835,272 | 4,471 | Shares | Sole | 2021-05-05 | |
| 2020-12-31 | $769,910 | 4,560 | Shares | Sole | 2021-01-25 | |
| 2020-09-30 | $629,973 | 4,256 | Shares | Sole | 2020-10-19 | |
| 2020-06-30 | $760,153 | 4,630 | Shares | Sole | 2020-08-05 | |
| 2020-03-31 | $653,371 | 4,710 | Shares | Sole | 2020-04-28 | |
| No filing history on record for this holder in this stock. | ||||||